Amgen INC (AMGN) Shares Declined While Shelton Capital Management Increased Stake

April 17, 2018 - By Andrea Pope

Amgen Inc. (NASDAQ:AMGN) Corporate LogoBig Money Sentiment increased to 1.22 in 2017 Q4. It has change of 0.23, from 2017Q3’s 0.99. The ratio improved due to AMGN positioning: 73 sold and 458 reduced. 122 funds amassed stakes and 527 increased stakes. Investors holded 555.05 million in 2017Q3 but now own 551.71 million shares or 0.60% less. Moors And Cabot stated it has 31,974 shs. Loomis Sayles & Ltd Partnership holds 3.32M shs. Wagner Bowman Corporation invested 0.08% in Amgen Inc. (NASDAQ:AMGN). Private Advisor Gru Limited Liability has invested 0.21% of its capital in Amgen Inc. (NASDAQ:AMGN). Geode Llc holds 8.11 million shs or 0.48% of its capital. Clean Yield Grp Inc holds 1.46% in Amgen Inc. (NASDAQ:AMGN) or 21,236 shs. Bbva Compass Retail Bank Inc holds 50,187 shs. Evergreen Ltd Liability Company invested 0.03% of its capital in Amgen Inc. (NASDAQ:AMGN). 1,285 are owned by D L Carlson Grp Inc Incorporated. Prudential Public Limited Company has invested 0.58% in Amgen Inc. (NASDAQ:AMGN). Miller Inv Ltd Partnership holds 0.28% or 5,229 shs. Sawgrass Asset Management owns 126,575 shs. Fca Tx invested in 1.33% or 19,142 shs. Robeco Institutional Asset Mngmt Bv holds 0.14% in Amgen Inc. (NASDAQ:AMGN) or 153,781 shs. Amer Assets Inv Management Lc has invested 0.67% in Amgen Inc. (NASDAQ:AMGN).

AMGN had 4 insider sales and 0 insider buys since December 12, 2017. This’s net activity of $1.11 million.

Based on the latest 2017Q4 regulatory filing with the SEC, Shelton Capital Management increased its holdings in Amgen Inc (AMGN) by 31.1%. By buying 22,483 shares Shelton Capital Management made the stock sank with 2.99%. The biological products (no diagnostic substances) company announced $16.48M value for the 2017Q4. Now the institutional investor is holding 94,776 shares, compared to the 72,293 from the previous quarter. $115.23B is the market cap of Amgen Inc. On during the last trading session the stock increased $1.0522 or 0.61%, reaching $172.4322.Amgen Inc. has volume of 248,191 shares. Since April 17, 2017 AMGN has risen 3.78% and is uptrending. The stock underperformed the S&P500 by 7.77%.

According to a filing the Shelton Capital Management’s stake in Intel Corp (NASDAQ:INTC) was reduced by 77,516 shares to 486,733 shares valued at $22.47M in 2017Q4. It operates about $1.01 billion and $1.56 billion US Long portfolio. For a total of 93,464 shares it reduced its holding in Micron Technology Inc (NASDAQ:MU) by 95,035 shares in the quarter, and has cut its stake in United Rentals Inc (NYSE:URI).

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Total analysts of 14 have positions in Amgen Inc (NASDAQ:AMGN) as follows: 7 rated it a “Buy”, 0 with “Sell” and 7 with “Hold”. The positive are 50%. Since October 20, 2017 according to StockzIntelligence Inc Amgen Inc has 22 analyst reports. The company rating was maintained by BMO Capital Markets on Friday, October 20. The stock rating was maintained by PiperJaffray with “Overweight” on Friday, February 2. On Thursday, February 1 the stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given by Cowen & Co. In Thursday, October 26 report BMO Capital Markets maintained it with “Market Perform” rating and $192 target. On Tuesday, January 23 Argus Research upgraded the shares of AMGN in report to “Buy” rating. On Monday, February 12 Mizuho maintained Amgen Inc. (NASDAQ:AMGN) rating. Mizuho has “Buy” rating and $200.0 target. On Monday, February 5 the stock has “Hold” rating by Atlantic Securities. On Thursday, October 26 the rating was maintained by RBC Capital Markets with “Hold”. On Monday, January 22 the company was maintained by RBC Capital Markets. On Thursday, October 26 the stock of Amgen Inc. (NASDAQ:AMGN) has “Overweight” rating given by Morgan Stanley.

Amgen Inc. (NASDAQ:AMGN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: